Location: Home> Products> Star Products
Click to return to the list
Common name: Imatinib mesylate
English name: Imatinib Mesylate Tablets
Approval number: National Pharmaceutical Standard H20143340
Specifications: 0.1gx10 tablets x6 boards / box
Indications: Treatment of chronic, accelerated, or acute phase of Philadelphia chromosome-positive chronic myelogenous leukemia (Ph + CML); treatment of adult patients with malignant gastrointestinal stromal tumor (GIST) that cannot be removed and / or metastatic Treatment of relapsed and refractory Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph + ALL) in adults.